查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
基因型鑑定化驗的全球市場(2022年～2029年)
市場調查報告書
商品編碼
1065209

基因型鑑定化驗的全球市場(2022年～2029年)

Global Genotyping Assay Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 185 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供全球基因型鑑定化驗市場相關調查分析，提供市場動態，產業分析，市場分析，競爭情形等系統性資訊。

目錄

第1章 全球基因型鑑定化驗市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球基因型鑑定化驗市場-市場定義和概要

第3章 全球基因型鑑定化驗市場-摘要整理

  • 市場明細:各產品
  • 市場明細:各技術
  • 市場明細:各終端用戶
  • 市場明細:各地區

第4章 全球基因型鑑定化驗市場-市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球基因型鑑定化驗市場-產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 未滿足需求

第6章 全球基因型鑑定化驗市場-COVID-19分析

  • 市場COVID-19分析
    • COVID-19前的市場方案
    • 目前COVID-19市場方案
    • COVID-19後的市場方案/未來市場方案
  • COVID-19的價格的動態
  • 需求與供給的頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商策略性舉措
  • 結論

第7章 全球基因型鑑定化驗市場:各產品

  • 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%):各產品
  • 市場魅力指數:各產品
    • 試劑和套件
    • 設備
    • 其他

第8章 全球基因型鑑定化驗市場:各技術

  • 簡介
  • 市場規模分析，及與前一年同期比較成長分析(%):各技術
  • 市場魅力指數:各技術
    • PCR*
    • 微陣列
    • 序列
    • 毛細管電泳法
    • 其他

第9章 全球基因型鑑定化驗市場:各終端用戶

  • 簡介
    • 市場規模分析，及與前一年同期比較成長分析(%):各終端用戶
    • 市場魅力指數:各終端用戶
  • 製藥企業及生物製藥企業*
    • 簡介
    • 市場規模分析，100萬美元(2020年～2029年)，及與前一年同期比較成長分析(%)(2021年～2029年)
  • 診斷實驗室·研究實驗室
  • 其他

第10章 全球基因型鑑定化驗市場:各地區

  • 簡介
    • 市場規模分析，100萬美元(2020年～2029年)，及與前一年同期比較成長分析(%)(2021年～2029年):各地區
    • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東和非洲

第11章 全球基因型鑑定化驗市場-競爭情形

  • 主要的開發與策略
  • 企業佔有率分析
  • 產品的基準

第12章 全球基因型鑑定化驗市場-企業簡介概要

  • Illumina*
    • 企業概要
    • 產品系列及說明
    • 主要亮點
    • 財務概要
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • LGC, Biosearch Technologies
  • Roche Diagnostics
  • Fluidigm Corporation
  • PerkinElmer
  • Integrated DNA Technologies

第13章 全球基因型鑑定化驗市場-DataM

  • 附錄
  • 關於本公司·服務
  • 諮詢方式
簡介目錄
Product Code: DMBT4860

Market Overview

The global genotyping assay market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Genotyping is the process of determining differences in an individual's genetic make-up (genotype) by examining the individual's DNA sequence and comparing it to the sequence of another individual or a reference sequence using biological assays.

Market Dynamics

The factors influencing the global genotyping assay market are the growing importance of genotyping assay, and the technological advancements are expected to drive the market growth.

The growing importance of genotyping assay is expected to drive the market growth in the forecast period

Researchers can use genotyping to investigate genetic variants such as single nucleotide polymorphisms (SNPs) and large structural changes in DNA. High-throughput genomic technologies like next-generation sequencing (NGS) and microarrays allow for a more in-depth understanding of disease aetiology at the molecular level.

With multiple genomic targets potentially contributing to disease, an analysis must be flexible and precise. Data analysis tools for SNP genotyping and copy number variation (CNV) can analyze results for millions of markers and probes and detect sample outliers, providing insight into the functional consequences of genetic variation. Genotyping can help us understand disease mechanisms, predict an individual's risk of developing certain diseases, and even aid in developing personalized therapies. Biosystems for Applied Research TaqMan SNP genotyping assays have been used to identify variants linked to blood disorders and a variety of other diseases. TaqMan SNP genotyping assays require a double-stranded DNA template, the Taq polymerase enzyme, and two forward and reverse primers specific to the amplified sequence. Unlike gene expression qPCR, SNP detection necessitates using two probes with different fluorescent reporters. This allows homozygous and heterozygous samples to be distinguished.

Limitations associated with genotyping assay is expected to hamper the market growth

WGR genotyping has traditionally been carried out using paired-end Illumina technology, which, according to a survey, costs approximately $400 per sample for a genome of 1 Gb and 10 average sequencing depth. WGR-based GWAS, which typically involves a few hundred individuals, may cost several hundred dollars for crops with large genomes. Reduced average sequencing depth can reduce WGR costs; however, this may result in an unacceptable number of genotyping errors.

Furthermore, although genotyping errors affect most data and can significantly impact a study's biological conclusions, they are too often overlooked. Genotyping errors can arise from various complex and sometimes cryptic causes, including the primary DNA sequence, low quality or quantity of the DNA sample, biochemical artifacts, or human factors.

COVID-19 Impact Analysis

Several alarming VOC lineages have been linked to increased transmissibility, virulence, or the ability to evade the immune response gained from prior infection or vaccination. Mutations in the viral genome of these variants are associated with a change in 'fitness' or are unique to their lineage and can be used as genotyping genetic markers. It distinguishes between the wild-type (WT) strain and other variants. To combat these new variants, including the Omicron/B.1.1.529 variant, constant monitoring and the rapid development of novel early-detection tools are required. Although next-generation sequencing (NGS) methods exist for variant surveillance, qRT-PCR and Pyrosequencing provide significantly faster options for highly sensitive detection of specific mutations and VOCs, with same-day genotyping results. QIAGEN applies its expertise in assay design for these two technologies to provide the lab with high-performance genotyping assays. Hence, the global genotyping assay market is expected to be positively impacted.

Segment Analysis

By technology, the PCR segment is expected to dominate the market in the forecast period

PCR genotyping employs the widely used polymerase chain reaction technique for genetic analysis. DNA or RNA sequences are amplified with specific primers and electrophoretically analyzed for size and quality before being extracted and purified. Genotyping enables researchers to investigate large structural variations and small genetic changes in DNA, such as single nucleotide polymorphisms (SNPs). Real-time PCR is a high throughput genotyping method that uses molecular probes to produce quick and accurate results. Real-time PCR is a high throughput genotyping method that uses molecular probes to produce quick and accurate results. Our qPCRBIO Probe Mixes are compatible with all dual-labeled allele-specific probes and can be used for reliable allelic discrimination. Another real-time genotyping system is High-Resolution Melt, a post-PCR application (HRM).

Many companies are launching PCR genotyping assay products and are expected to drive market growth. For instance, on 2nd February 2021, Novacyt S.A launched PCR genotyping assay portfolio under the brand name SNPsig, to diagnose new variants of SARS-CoV-2.

Geographical Analysis

North America region is expected to hold the largest market share in the global genotyping assay market

The greater technological and government support and the presence of major players in the region are expected to drive the market growth. Furthermore, increased R&D funding is expected to fuel market growth over the forecast period. Thermo Fisher Scientific is based in the United States that manufactures and distributes scientific instruments, reagents and consumables, and software services. TaqMan SNP Genotyping Assay uses TaqMan 5'nuclease chemistry to amplify and detect specific polymorphisms in purified genomic DNA samples. Each assay uses two sequence-specific primers, and two TaqMan minor groove binder (MGB) probes with non-fluorescent quenchers to genotype individuals for a single nucleotide polymorphism (SNP) (NFQ).

Competitive Landscape

The global genotyping assay market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Thermo Fisher Scientific, Illumina, QIAGEN, Agilent Technologies, LGC, Biosearch Technologies, Roche Diagnostics, Fluidigm Corporation, PerkinElmer, Bio-Rad Laboratories, Integrated DNA Technologies.

Illumina

Overview: Illumina, Inc. is a company based in the United States. Illumina was founded on April 1, 1998. The company develops, manufactures, and sells integrated systems for analyzing genetic variation and biological function.

Product Portfolio: The iSeq 100 System is well-suited for small whole-genome sequencing (for example, bacteria, viruses, and plasmids), targeted sequencing of a subset of genes or gene regions, gene expression analysis, and 16S metagenomics.

Key Development: On January 8th, 2018, The iSeqTM 100 Sequencing System was launched by Illumina, Inc. The new next-generation sequencing (NGS) system provides exceptional data accuracy at a low capital cost, allowing Illumina technology accessible to virtually any lab.

Why Purchase the Report?

Visualize the composition of the global genotyping assay market segmentation by product, by technology, and end-user highlighting the key commercial assets and players.

Identify commercial opportunities in global genotyping assay market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global genotyping assay market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global genotyping assay market report would provide an access to an approx. 45+market data table, 40+figures and 185 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Genotyping Assay Market- By Product

Reagents & Kits

Instruments

Other

Global Genotyping Assay Market-By Technology

PCR

Microarrays

Sequencing

Capillary Electrophoresis

Other

Global Genotyping Assay Market- By End User

Pharmaceutical and Biopharmaceutical Companies

Diagnostic and Research Laboratories

Other

Global Genotyping Assay Market- By Region

North America

Europe

South America

Asia Pacific

Middle East and Africa

Table of Contents

1. Global Genotyping Assay Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Genotyping Assay Market- Market Definition and Overview

3. Global Genotyping Assay Market- Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market SnippetBy Technology
  • 3.3. Market Snippet By End User
  • 3.4. Market Snippet By Region

4. Global Genotyping Assay Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The growing importance of genotyping assay
    • 4.1.2. Restraints:
      • 4.1.2.1. Limitations associated with genotyping assay
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Genotyping Assay Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Global Genotyping Assay Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Genotyping Assay Market- By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 7.3. Market Attractiveness Index, By Product
    • 7.3.1. Reagents & Kits
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.2. Instruments
    • 7.2.3. Other

8. Global Genotyping Assay Market-By Technology

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Technology
  • 8.3. Market Attractiveness Index,By Technology
    • 8.3.2. PCR*
      • 8.3.2.1.1. Introduction
      • 8.3.2.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 8.3.3. Microarrays
    • 8.3.4. Sequencing
    • 8.3.5. Capillary Electrophoresis
    • 8.3.6. Other

9. Global Genotyping Assay Market- By End User

  • 9.1. Introduction
    • 9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.3. Market Attractiveness Index, By End User
  • 9.2. Pharmaceutical and Biopharmaceutical Companies*
    • 9.2.2. Introduction
    • 9.2.3. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic and Research Laboratories
  • 9.4. Other

10. Global Genotyping Assay Market- By Region

  • 10.1. Introduction
    • 10.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.3. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.2. Introduction
    • 10.2.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Technology
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.2. Introduction
    • 10.3.3. Key Region-Specific Dynamics
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Technology
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.2. Introduction
    • 10.4.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Technology
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.2. Introduction
    • 10.5.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Technology
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.2. Introduction
    • 10.6.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Technology
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Genotyping Assay Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Genotyping Assay Market- Company Profiles

  • 12.1. Illumina*
    • 12.1.2. Company Overview
    • 12.1.3. Product Portfolio and Description
    • 12.1.4. Key Highlights
    • 12.1.5. Financial Overview
  • 12.2. Bio-Rad Laboratories
  • 12.3. Thermo Fisher Scientific
  • 12.4. QIAGEN
  • 12.5. Agilent Technologies
  • 12.6. LGC, Biosearch Technologies
  • 12.7. Roche Diagnostics
  • 12.8. Fluidigm Corporation
  • 12.9. PerkinElmer
  • 12.10. Integrated DNA Technologies

LIST NOT EXHAUSTIVE

13. Global Genotyping Assay Market- DataM

    • 13.1.2. Appendix
    • 13.1.3. About Us and Services
    • 13.1.4. Contact Us